Buspirone Induces Weight Loss and Normalization of Blood Pressure via the Stimulation of PPARδ Dependent Energy Producing Pathway in Spontaneously Hypertensive Rats

INTRODUCTION: Buspirone, as a partial agonist for a 5-hydroxytryptamine (serotonin) receptor 1A (5-HT1A), has been prescribed as an anxiolytic drug for patients. In addition, the lowering effect of serotonin on blood pressure was reported in hypertensive animal model. We investigated the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yong-Jik, Kim, Hyun-Min, Jang, Yoo-Na, Han, Yoon-Mi, Seo, Hong Seog, Jung, Tae Woo, Jeong, Ji Hoon, Lee, Hyun Jung, Jung, Kyung Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164918/
https://www.ncbi.nlm.nih.gov/pubmed/37168052
http://dx.doi.org/10.1155/2023/7550164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164918/
https://www.ncbi.nlm.nih.gov/pubmed/37168052
http://dx.doi.org/10.1155/2023/7550164

Ejemplares similares